To assess the clinical efficacy of the combined treatment of imatinib plus HU based on the objective overall response OR rateThis objective overall response rate is calculated as the rate of best overall response of complete response plus partial response CRPR to treatment
Data and Resources
- A phase II open-label multi-centre single-arm study evaluating the efficacy of Glivec plus Hydroxyurea HU in patients with progressive glioblastoma multiforme GBM not receiving enzyme inducing anticonvulsant drugs EIACDsjson
To assess the clinical efficacy of the combined treatment of imatinib plus...
|Release Date|| |
|Public Access Level|| |